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Cost Action B12 Conference
Radiotracers for in vivo assessment
of biological functions
22–23 April 2005, Warsaw, Poland
This meeting was held in the Hotel “Europejski” in the very
heart of Warsaw, the capital of Poland. COST — European Coop-
eration in the field of Scientific and Technical Research is an inter-
governmental network for cooperation in research, established in
1971. It is used by the scientific communities of 34 European coun-
tries and Israel. The funds provided by COST (only around
20 million euro) support the cooperation networks, through which,
more than 30,000 European scientists are involved in research
having a total value exceeding 2 billion euro per annum.
The COST Warsaw conference gathered radiopharmacists and
specialists of nuclear medicine from Austria, Belgium, Brazil, Can-
ada, the Czech Republic, Finland, France, Germany, Greece, Ita-
ly, Korea, the Netherlands, Poland, Portugal, Russia, Spain, Swi-
tzerland, Sweden, the United Kingdom, Uruguay and the USA.
The local organiser was Dr. Renata Mikolajczak from the Radio-
isotope Centre POLATOM, Otwock/Swierk near Warsaw/Poland.
The proceedings comprised 8 programme lectures, 20 oral
presentations, 30 poster presentations and 5 working group re-
ports. These proceedings have been published as Supplement A
of Nuclear Medicine Review — CEE 2005; 8. 1–27.
The scientific programme was focused mainly on the follo-
wing areas:
— the radioligands for different types of glutaminic, nicotinic and
serotoninergic receptors in neuropsychiatric disorders;
— heart receptors assessed with 11C and 18F radiolabelled nor-
adrenaline analogues;
— radiolabelled peptides in diagnostics and therapy;
— 11b-hydroxylase enzyme inhibitors in endocrine disorders;
— technetium chelates.
The most memorable lectures were the presentations by:
— I. Carrio — the President of EANM (Barcelona, Spain) on the
detection of arteriosclerotic plaques, as a new challenge in
cardiovascular medicine;
— S. Aime (Ivrea, Italy) on MRI routes to cellular and molecular
imaging;
— C.A. Mathis and W.E. Klunk (Pittsburgh, USA) on the develop-
ment and application of amyloid imaging agents for Alz-
heimer’s disease;
— G.J.Meyer, H.J.Helmeka and W.Knapp (Hannover, Germany)
on the production and labelling of astatine-211;
— A. Hubalewska, R. Mikolajczak et al (Cracow, Poland) on the
application of 9mTc-EDDA/HYNIC-TATE scintigraphy in detec-
tion and staging of carcinoid tumours.
All abstracts are available in Supplement A of Nuclear Medi-
cine Review — CEE 2005; 8. 1–27.
Warsaw is not exactly the most beautiful city in Central Eu-
rope, as some of its inhabitants believe, but the weather was good,
the organisation was excellent and this event will probably be long
remembered by all participants. Congratulations to Dr. Mikolajczak
as the local organiser and to the COST community!
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1st German-Polish Symposium of Nuclear Medicine,
Frankfurt/Oder–Słubice 4th–5th February, 2005
Contact between Polish and German nuclear medicine has
recently been limited to occasional meetings of individuals. With
the extension of the European Union, a need for closer, official
cooperation has been expressed by both countries. In 2003, the
Berlin-Brandenburg Society of Nuclear Medicine (BBGN) initiated
cooperation with the Polish Society of Nuclear Medicine (PTMN).
The Presidents of these Societies decided that a common confer-
ence would be the best starting point for better bilateral contact.
The 1st Polish-German Symposium took place on 4th–5th Fe-
bruary, 2005. The venue of the meeting was symbolic: the Col-
legium Polonicum of Polish-German Viadrina University, located
on the river Odra/Oder, close to the entrance of the bridge con-
necting Frankfurt on the Oder/Odra River and Słubice on the Odra/
/Oder River — German and Polish parts of what was formerly one
city. After the scientific sessions, the participants crossed the riv-
er and the border to take part in a get-together party or for a sight-
-seeing tour in freezing winds.
The Symposium gathered ca. 80 participants from both coun-
tries; quite a number for the first meeting of its kind. The meeting
was opened by two honorary guests: Prof. Wolfram Knapp, Pre-
sident of the German Society of Nuclear Medicine (DGN) and Prof.
Piotr Lass, President of the Polish Society of Nuclear Medicine
(PTMN) and — surprisingly — Prof. Knapp held his opening
speech in Polish language!
The main subject of the meeting was “Radioiodine therapy of
benign thyroid diseases”. Lecturers from both countries present-
ed different aspects of radioiodine therapy: pathogenesis of thy-
roid diseases, dosimetry, the problem of orbitopathy and others.
At the end of the scientific session, 7 original papers were pre-
sented by participants. All lectures and presentations were
accompanied by interesting discussions. Finally, we had an op-
portunity to discuss current economical and organizational issues
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of nuclear medicine in both countries, now that we are all citizens
of a United Europe. For better understanding, native languages
were spoken with simultaneous translation.
The delicious dinner and dance in the Oderspeicher (Oder
River Granary), a friendly restaurant on the German bank of the
river, as well as the industrial exhibition of a dozen German and
Polish companies, were perfect opportunities to get to know each
other better on a more personal level. Such bilateral meetings will
be continued in future years, perhaps during a warmer month. We
also hope that other forms of cooperation will develop, such as
common scientific projects or visits to each others’ departments.
This is of special importance nowadays, as our regions and coun-
tries are linked to each other more and more closely.
We would like to thank the Presidents of the Societies for their
initiating idea and support, all the participants for their involve-
ment and good atmosphere and the industry for their assistance.
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